Source:http://linkedlifedata.com/resource/pubmed/id/19940306
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
22
|
pubmed:dateCreated |
2009-11-26
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1533-4406
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
26
|
pubmed:volume |
361
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2193-4; author reply 2195
|
pubmed:meshHeading |
pubmed-meshheading:19940306-Clinical Trials as Topic,
pubmed-meshheading:19940306-Heroin,
pubmed-meshheading:19940306-Humans,
pubmed-meshheading:19940306-Injections, Intravenous,
pubmed-meshheading:19940306-Methadone,
pubmed-meshheading:19940306-Opioid-Related Disorders,
pubmed-meshheading:19940306-United States
|
pubmed:year |
2009
|
pubmed:articleTitle |
Diacetylmorphine versus methadone for opioid addiction.
|
pubmed:publicationType |
Letter,
Comment
|